Skip to main content
. 2025 Mar 30;27(8):euaf076. doi: 10.1093/europace/euaf076

Table 4.

Typical indications and contraindications of major AADs

Modified VW class AAD Main indications Not to be used/main contraindication
0 Ivabradine Inappropriate sinus tachycardia AF termination
Ia Ajmaline AF (pre-excitation) termination
MVT (no significant SHD) termination
BrS, HFrEF
Quinidine PVT (channelopathies) prevention Long QT
Procainamide MVT (SHD) termination HFrEF
Disopyramide AF (vagotonic) prevention HFrEF
Ib Lidocaine PVT/VF (ischaemia) termination Bradycardia
Mexiletine TdP (LQTS 3) prevention Bradycardia
Phenytoin JET (digitalis toxicity) termination Bradycardia
Ic Flecainide/Propafenone AF (idiopathic) prevention/termination
WPW syndrome
BrS, SHD
Antazoline AF (idiopathic) termination Bradycardia, SHD
Pilsicainide AF (idiopathic) termination SHD
Id Ranolazine AF prevention/termination Long QT except LQT3
IIa β1-blockers (e.g. bisoprolol, metoprolol) AF/AFL rate control
VT/PVCs (idiopathic)
Bradycardia
β1- + β2-blockers
(e.g. nadolol, propranolol)
TdP (LQTS 1 and 2) prevention
CPVT
Bradycardia
IIb Isoprenaline TdP (acquired LQTS)
PVT (BrS)
CPVT
IIc Atropine Sinus bradycardia Inappropriate sinus tachycardia
IId Digoxin AF/AFL rate control Amyloidosis
IIe Adenosine PSVT termination Asthma/COPD
III Amiodarone AF/AFL (HFrEF) prevention/termination
MVT (SHD) prevention/termination
Bradycardia
Dronedarone AF/AFL (SHD) prevention Permanent AF, HFrEF
Dofetilide AF/AFL (HFrEF) prevention Long QT
Ibutilide AFL termination Long QT
Sotalol MVT (SHD) prevention CKD, hypokalaemia, hypomagnesaemia or bradycardia
Vernakalant AF (≤7 d) termination Aortic stenosis, NYHA III/IV
IV Verapamil/
Diltiazem
AF/AFL rate control
VT (fascicular) prevention/termination
MVT (SHD), HFrEF

Conditions for indications and contraindications are stated in brackets.

Abbreviations: AADs, anti-arrhythmic drugs; AF, atrial fibrillation; AFL, atrial flutter; BrS, Brugada syndrome; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CPVT, catecholaminergic polymorphic ventricular tachycardia; HFrEF, heart failure with reduced ejection fraction; JET, junctional ectopic tachycardia; LQTS, long QT syndrome; LVEF, left ventricular ejection fraction; MVT, monomorphic VT; PVC, premature ventricular contraction; PVT, polymorphic ventricular tachycardia; RVOT, right ventricular outflow tract; SHD, structural heart disease; TdP, torsades de pointes; VF, ventricular fibrillation; VT, ventricular tachycardia; WPW, Wolff–Parkinson–White.